Mayu Nakagawa, Toshihide Matsumoto, Ako Yokoi, Miki Hashimura, Yasuko Oguri, Ryo Konno, Yu Ishibashi, Takashi Ito, Kensuke Ohhigata, Yohei Harada, et al. Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma. Molecular oncology. 2023
Yui Kobayashi, Ako Yokoi, Miki Hashimura, Yasuko Oguri, Ryo Konno, Toshihide Matsumoto, Masataka Tochimoto, Mayu Nakagawa, Yu Ishibashi, Takashi Ito, et al. Nucleobindin-2 Mediates Transforming Growth Factor-β1-Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1-High Uterine Carcinosarcoma. The American journal of pathology. 2023. 193. 8. 1116-1128
Akemi Inoue, Toshihide Matsumoto, Yuka Ito, Makoto Saegusa, Hiroyuki Takahashi. TP53 positivity combined with high fibrinogen expression defines a subtype of oral squamous cell carcinoma with an unfavorable prognosis. Human pathology. 2022. 130. 25-35
Ako Yokoi, Marina Minami, Miki Hashimura, Yasuko Oguri, Toshihide Matsumoto, Yoshinori Hasegawa, Mayu Nakagawa, Yu Ishibashi, Takashi Ito, Kensuke Ohhigata, et al. PTEN overexpression and nuclear β-catenin stabilization promote morular differentiation through induction of epithelial-mesenchymal transition and cancer stem cell-like properties in endometrial carcinoma. Cell communication and signaling : CCS. 2022. 20. 1. 181-181
Hiroyuki Takahashi, Hirono Watanabe, Miki Hashimura, Toshihide Matsumoto, Ako Yokoi, Mayu Nakagawa, Yu Ishibashi, Takashi Ito, Kensuke Ohhigata, Makoto Saegusa. A combination of stromal PD-L1 and tumoral nuclear β-catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal carcinoma. The journal of pathology. Clinical research. 2022. 8. 5. 458-469
